Growth Metrics

Regenerex Pharma (RGPX) Cash from Operations (2011 - 2025)

Regenerex Pharma (RGPX) reported Cash from Operations of 519355.0 for Q3 2025, down 310.21% year-over-year from 247060.64 in Q3 2024, and down 8.66% on a QoQ basis from 477943.0 in Q2 2025.

Regenerex Pharma (RGPX) has 13 years of Cash from Operations data on file, last reported at 519355.0 in Q3 2025.

  • Quarterly Cash from Operations fell 310.21% year-over-year to 519355.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 2440711.0 (down 605.0% YoY) and the FY2025 annual result came in at 1625351.0, down 255.23% from the prior year.
  • Cash from Operations declined to 519355.0 in Q3 2025 per RGPX's latest filing, from 477943.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 1362.0 in Q1 2022 and bottomed at 1284700.0 in Q1 2025.
  • The 5-year median for Cash from Operations is 59883.5 (2024), against an average of 178931.83.
  • The widest annual swing landed in 2022, when Cash from Operations jumped 66.56%; it then tumbled 2030.79% in 2024.
  • Tracing RGPX's Cash from Operations over 5 years: stood at 17593.0 in 2021, then tumbled by 62.72% to 28628.0 in 2022, then tumbled by 248.7% to 99827.0 in 2023, then slumped by 58.99% to 158713.0 in 2024, then plunged by 227.23% to 519355.0 in 2025.
  • Per Business Quant, the three latest RGPX Cash from Operations figures stand at 519355.0 (Q3 2025), 477943.0 (Q2 2025), and 1284700.0 (Q1 2025).

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 -519,355.00
Sep 30, 2025 -519,355.00
Jun 30, 2025 -477,943.00
Jun 30, 2025 -477,943.00
Mar 31, 2025 -1.28 Mn
Mar 31, 2025 -1.28 Mn
Dec 31, 2024 -158,713.00
Dec 31, 2024 -158,713.00
Sep 30, 2024 -126,606.00
Sep 30, 2024 -126,606.00
Jun 30, 2024 -55,332.00
Jun 30, 2024 -55,332.00
Mar 31, 2024 -64,435.00
Mar 31, 2024 -64,435.00
Dec 31, 2023 -99,827.00
Dec 31, 2023 -99,827.00
Sep 30, 2023 -172,049.00
Sep 30, 2023 -172,049.00
Jun 30, 2023 -121,237.00
Jun 30, 2023 -121,237.00
Mar 31, 2023 -3,024.00
Mar 31, 2023 -3,024.00
Dec 31, 2022 -28,628.00
Dec 31, 2022 -28,628.00
Sep 30, 2022 -9,444.00
Sep 30, 2022 -9,444.00
Jun 30, 2022 -35,068.00
Jun 30, 2022 -35,068.00
Mar 31, 2022 -1,362.00
Mar 31, 2022 -1,362.00
Dec 31, 2021 -17,593.00
Dec 31, 2021 -17,593.00
Sep 30, 2021 -28,239.00
Sep 30, 2021 -28,239.00
Jun 30, 2021 -17,218.00
Jun 30, 2021 -17,218.00
Dec 31, 2020 -16,724.00
Dec 31, 2020 -16,724.00
Sep 30, 2020 -11,703.00
Sep 30, 2020 -11,703.00
Jun 30, 2020 -9,125.00
Jun 30, 2020 -9,125.00
Mar 31, 2020 -512,139.00
Mar 31, 2020 -512,139.00
Dec 31, 2019 66,209.00
Dec 31, 2019 66,209.00
Sep 30, 2019 137,045.00
Sep 30, 2019 137,045.00
Jun 30, 2019 17,706.00
Jun 30, 2019 17,706.00
Mar 31, 2019 23,536.00
Mar 31, 2019 23,536.00
Dec 31, 2018 22,399.00
Dec 31, 2018 22,399.00
Sep 30, 2018 214.00
Sep 30, 2018 214.00
Jun 30, 2018 910.00
Jun 30, 2018 910.00
Mar 31, 2018 8,291.00
Mar 31, 2018 8,291.00
Dec 31, 2017 7,601.00
Dec 31, 2017 7,601.00
Sep 30, 2017 3,127.00
Sep 30, 2017 3,127.00
Jun 30, 2017 17,103.00
Jun 30, 2017 17,103.00
Mar 31, 2017 338.00
Mar 31, 2017 338.00
Nov 30, 2014 -26,037.00
Nov 30, 2014 -26,037.00
Aug 31, 2014 -4,130.00
Aug 31, 2014 -4,130.00
May 31, 2014 -32,185.00
May 31, 2014 -32,185.00
Feb 28, 2014 -9,289.00
Feb 28, 2014 -9,289.00
Nov 30, 2013 -6,814.00
Nov 30, 2013 -6,814.00
Aug 31, 2013 -20,098.00
Aug 31, 2013 -20,098.00
May 31, 2013 -24,411.00
May 31, 2013 -24,411.00
Feb 28, 2013 -3,000.00
Feb 28, 2013 -3,000.00
Nov 30, 2012 -5,600.00
Nov 30, 2012 -5,600.00
Aug 31, 2012 -28,393.00
Aug 31, 2012 -28,393.00
May 31, 2012 -9,005.00
May 31, 2012 -9,005.00
Feb 29, 2012 -14,518.00
Feb 29, 2012 -14,518.00
Aug 31, 2011 -30,707.00
Aug 31, 2011 -30,707.00